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Abstract
“The National Spina Bifida Patient Registry: Past, Present, and Future” was presented at the Spina 
Bifida World Congress, March 17, 2017, San Diego, California. This commentary provides a 
summary of registry activities including the reason for development, a description of the clinic 
participants and their patients who are participating, analytic works and publications. Two specific 
efforts that are related to the work of the registry, a urologic protocol to preserve renal function for 
newborns and young children, and a skin breakdown prevention bundle developed and 
implemented in registry clinics, are highlighted.
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1. Introduction
It is my pleasure to describe the work at the Centers for Disease Control and Prevention 
(CDC) to improve health outcomes and quality of life among people living with spina bifida. 
I do this on behalf of my colleagues on the Rare Disorders and Health Outcomes Team in 
the National Center on Birth Defects and Developmental Disabilities, CDC, and the 
healthcare and research professionals who collaborate with us in development, 
enhancements and data analysis from participating spina bifida clinics.
My comments will address the origin and purpose of the National Spina Bifida Patient 
Registry (NSBPR), objectives, what we have learned thus far, current activities, and plans 
for the future.
2. Background
In 2003, CDC, the Spina Bifida Association (SBA), the Agency for Healthcare Research and 
Quality (AHRQ), and the National Institutes of Health (NIH) sponsored a conference 
entitled “Evidence-Based Practice in Spina Bifida: Developing a Research Agenda” after 
which the proceedings were published in booklet form by Liptak (2003) [1]. In 2006, an 
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assessment of spina bifida clinics in the United States conducted on behalf of the Spina 
Bifida Association by the Delmarva Foundation for Medical Care [Unpublished report], 
found variation in clinical services provided, and the impact of the care provided had not 
been evaluated. Staffing and services provided differed among clinics. Funded by congress, 
CDC collaborated with SBA to develop a clinical patient registry to accomplish three things: 
evaluate how practice affects patient outcomes; provide a foundation for clinical research; 
and improve health outcomes and quality of life for people affected by spina bifida.
With this charge, CDC has been collaborating with participating spina bifida (SB) clinics 
and receiving data describing clinical care provided and outcomes realized. Practices and 
outcomes can be compared among clinics so that best practices can be shared. Gaps in 
knowledge of care and outcomes can be identified using the registry and prioritized for 
future research, some of which can be accomplished using the aggregate registry data.
3. Implementation
Registry data collection began in 2009 when CDC funded 10 spina bifida clinics to establish 
the Registry and the data collection process. In 2011, 19 clinics participated to broaden and 
continue the collection of data to improve the care of people living with spina bifida. Today, 
14 clinics are funded by CDC, and seven clinics are self-funded (Fig. 1). The focus in the 
current funding cycle, ending in 2019, is to implement research to describe best practices, 
compare differences in interventions and outcomes among clinics and to examine data 
longitudinally in children and adults.
Publications to date include a paper describing the methods to implement a registry to 
collect data [2]; a description of the initial registry participants [3]; an investigation of the 
association between sociodemographic characteristics and patient outcomes [4]; and 
identification of factors associated with mobility [5]. A description of the methods for 
developing and refining a urologic protocol for newborns and young children with spina 
bifida has also been published [6]. A paper titled, “Factors Associated with Pressure Ulcers 
in Individuals with Spina Bifida” [7] provides an example of how Registry data have been 
used to identify and promote improved care, and will be described in more detail below.
Figure 2 depicts how data flow from the clinics to a secure hosting site where data are 
encrypted and registry variables are parsed off and sent to CDC, as approved by each clinic’s 
Institutional Review Board. Aggregate data are compiled at the CDC and shared with the 
participating clinics who receive clinic-specific data reports as well.
4. Data
As of March 2017, the NSBPR includes 7,924 participants. Data collected include 
characteristics of the person with spina bifida and his/her family, such as grade in school, 
insurance, height and weight; the surgeries and procedures provided during the past year and 
throughout the life of the participant; results of urodynamics and sleep studies; bowel and 
bladder management techniques; and outcomes such as continence, mobility and skin 
breakdown.
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The Registry participants range in age from birth to 89 years: 20% were older than 18 years 
at the time of enrollment, 22% were of Hispanic ethnicity and the most frequent diagnosis 
was myelomeningocele (78%), followed by lipomyelomeningocele (14%). Patients with the 
other eligible diagnoses, meningocele, split cord malformation, terminal myelocystocele, 
and fatty filum, contribute less than 6% of all cases.
Categorizing Registry participants into two groups, those diagnosed with myelomeningocele 
and those with other diagnoses, we found that
• 77% with myelomeningocele have a history of shunt placement
• among those older than five years in both groups, urinary continence is 40–52%, 
bowel continence 47–69%, and
• 4% had prenatal back closure.
Table 1 provides more descriptive information about registry participants.
At each clinic visit, registry participants are asked about their work/school status. Table 2 
describes the vocational status of patients in the registry who are 22 years and older 
including those who are volunteering and those who are full time homemakers. Shunt 
placement is the most common surgery for patients with myelomeningocele and is included 
with other surgeries reported in Table 3. Surgeries for those with other eligible diagnoses are 
reported in Table 4.
Patient outcomes vary among clinics. Figure 3 exemplifies how outcomes data may vary 
among participating sites. In this figure, participating clinics are ranked by the prevalence of 
urinary continence among patients five years and older with a diagnosis of 
myelomeningocele. Examination of variation among clinic outcomes is expected to improve 
practices and processes as clinics with the lower proportions of favorable outcomes seek to 
emulate the practices of clinics with higher proportions of patients with favorable outcomes. 
We anticipate that providing these data to clinics will lead to identification and adoption of 
best practices, and ultimately, reduced variation in patient outcomes.
Analyses of Registry data in progress include description of treatments and interventions, 
which will highlight the associated challenges in decision-making; a comparison of 
variations among clinics in procedures patients have undergone; trends in outcomes over 
time; and bowel and bladder continence management techniques among adult patients.
5. Related projects
In order to address the question “what is the optimal bladder management protocol to 
preserve renal function in the newborn and young child with spina bifida?” CDC convened a 
group of urologic healthcare professionals, nephrologists, clinical epidemiologists, 
community advocates, and CDC personnel to develop a protocol to test for effectiveness.
Nine sites were funded in 2014 to prospectively treat all newborns with spina bifida using a 
single consensus-based protocol. Using the NSBPR, data collection began in February, 
2015. To date, 153 infants have been enrolled, 79% of those eligible at participating clinics.
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The urology protocol was developed using an iterative quality improvement design. 
Participating clinics commit to treat all newborns with a diagnosis of myelomeningocele 
using the protocol. The protocol specifies the timing of follow-up visits, the type and 
frequency of diagnostic procedures, and the type and nature of any treatment-related 
interventions. Care may be customized for particular patients, which results in explanation 
and documentation of the need for the customization. These protocol deviations are later 
analyzed to identify the need for potential modifications of the original protocol for either a 
subset of patients or the entire population.
The protocol dictates that the newborn will be catheterized for three days with decreasing 
frequency as long as the bladder volumes remain below 30 ml. The parents will be trained to 
do intermittent catheterization, which will be prescribed to continue at home only when 
bladder residuals are greater than 30 milliliters, or there is grade three or four 
hydronephrosis. Prophylactic antibiotics will not be prescribed unless there is Grade Five 
reflux, and a renal bladder ultrasound will be performed every three months in the first year. 
In years one through five, the protocol requires annual visits that include a renal bladder 
ultrasound and serum creatinine, with urodynamics through three years of age unless the 
bladder is characterized as hostile. In the fifth year, a measurement of the glomerular 
filtration rate is added.
Of particular interest are the occurrence and management of urinary tract infections (UTI) 
and the differentiation between lab confirmed infections and those diagnosed and treated 
based on symptoms alone. Various definitions of UTI were considered and the definition of 
Madden-Fuentes and colleagues was chosen for this study [8]. This urology protocol is the 
first iterative quality improvement consensus-based protocol to establish the most effective 
and efficient practice guidelines for the infant and young child affected by 
myelomeningocele.
Information from the NSBPR is also influencing clinical practice in the area of skin 
breakdown prevention. Analysis of Registry data by Kim and colleagues [6] quantified the 
incidence of skin breakdowns reported between 2009 and 2012 among Registry participants 
at 26%; on their most recent visit, 19% of patients > 2 years old had skin breakdown.
A Working Group was convened. The work of the group included a review of the skin 
breakdown prevention literature and clinical practices of Registry clinics related to skin 
breakdown. Most clinics did not have specific tools to use to educate patients and families 
about the care of insensate skin.
In collaboration with the SBA, a Skin Breakdown Prevention Care Bundle was created. A 
Care Bundle is a set of interventions that, when used together, significantly improve patient 
outcomes. The Skin Breakdown Prevention Bundle includes a skin assessment tool, skin 
breakdown risk assessment tool, educational brochures for three age groups, and a poster for 
educating the patient and family. The content has been translated into Spanish.
The Skin Breakdown Prevention Care Bundle also includes an online training presentation 
for use of the bundle and a staff training manual that includes goals and activities to prevent 
skin breakdown relative to each risk factor. The Skin Breakdown Prevention Bundle was 
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implemented in 10 Registry clinics in 2016. Monitoring the use of the bundle is done 
through the registry. Clinics are informed quarterly of the proportion of patients seen who 
received the prevention information. Skin breakdown incidence by clinic is also reported. A 
visual reminder for the patient and family, as well as an electronic application that provides 
information based on the patient’s particular risk for skin breakdown, will be developed.
6. Conclusion
The NSBPR was implemented to improve the care and health outcomes of people living 
with spina bifida and to build a foundation for research. The activities of the Registry have 
led to collaboration among clinics. The variation in practice and outcomes is shared openly 
among participating clinics to provide opportunity for discussion about the causes of 
variation and the opportunities for improvement. Research using Registry data has begun to 
describe practice and outcome variation in spina bifida clinics. Future exploration of clinic 
processes and practices may continue to identify best practices, such as maintaining skin 
integrity, which, if adopted, could improve the health outcomes for all people living with 
spina bifida.
The reach and effectiveness of the NSBPR is enhanced by the activities of the SBA and their 
work to develop and implement the infrastructure for Spina Bifida Clinical Care Monitoring 
and Tracking. This system will monitor, track and evaluate patterns of care provided in spina 
bifida clinics with the goal of improving and standardizing care through evidence-based 
effectiveness analysis. This will result in a system that coordinates communication between 
clinics and local chapters, provides input into research priorities for the NSBPR, and 
educates and informs relevant parties: healthcare systems, healthcare professionals, people 
with spina bifida and their families, and payers, with the goal of supporting the adoption of 
best practices identified via the NSBPR and associated research and quality improvement 
projects.
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Geographic distribution of multidisciplinary clinics participating in the National Spina 
Bifida Patient Registry, 2017. Clinics participating in the registry and in the assessment of a 
urology protocol for newborns and young children, are indicated on this map by a red dot; 
clinics participating in the registry only are indicated by a green dot; and clinics that are 
participating in the registry and are self-funded are indicated by a gold dot.
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National spina bifida patient registry data flow.
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Percent of myelomeningocele patients aged 5+ years with urinary continence across clinics 
participating in the NSBPR (2009–2016) (N = 4,932).
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 Non-Hispanic white 63




 Some private 48
 Public 46









At the last reported annual visit.
**
Among those five years old or older.















Work/School status of patients with spina bifida, 22 years old or older (n = 1,183)
Vocational status Percent (%)
Employed, full- or part-time 35.7


























Antegrade continence enema 16
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